# Bioequivalence Study of Two Formulations of Pregabalin Capsules 150 mg

> **NCT02233777** · NA · COMPLETED · sponsor: **Dexa Medica Group** · enrollment: 20 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Pregabalin capsules 150 mg of Dexa Medica
- **DRUG:** Pregabalin capsules 150 mg of Pfizer Manufacturing Deutschland

## Key facts

- **NCT ID:** NCT02233777
- **Lead sponsor:** Dexa Medica Group
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-06
- **Primary completion:** 2014-06
- **Final completion:** 2014-06
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2014-09-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02233777

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02233777, "Bioequivalence Study of Two Formulations of Pregabalin Capsules 150 mg". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02233777. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*